Morten Ladekarl
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer (NCT05841420) | Morten Ladekarl | 2023-06-12 |
| Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment (NCT05695638) | Morten Ladekarl | 2020-07-01 |
Track Morten Ladekarl automatically
Every clearance here is in the API, with alerts when new ones post.